TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11683188

Group type: EXPERIMENTAL
Intervention: 1 micromol/kg/d manganese supplementation (group 1, n = 121)
Number of subjects: 244

Group type: COMPARATOR
Intervention: 0.0182 micromol/kg/d manganese supplementation (group 2, n = 123)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: 1 micromol/kg/d manganese supplementation (group 1, n = 78)
Number of subjects: 244

Group type: COMPARATOR
Intervention: 0.0182 micromol/kg/d manganese supplementation (group 2, n = 82)
Number of subjects: 244
Study: 9653434

Group type: EXPERIMENTAL
Intervention: New therapies for prevention and treatment of MAS
Number of subjects: 0
Study: 8778001

Group type: EXPERIMENTAL
Intervention: 30 micrograms pramlintide
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 100 micrograms pramlintide
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 300 micrograms pramlintide
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 2273080

Group type: EXPERIMENTAL
Intervention: Guanfacine 1 mg every night
Number of subjects: 102

Group type: COMPARATOR
Intervention: Prazosin 1 mg three times a day
Number of subjects: 102
Study: 6269789

Group type: EXPERIMENTAL
Intervention: 60 mg ranitidine intravenously
Number of subjects: 8

Group type: COMPARATOR
Intervention: 300 mg cimetidine intravenously
Number of subjects: 8
Study: 31644381

Group type: EXPERIMENTAL
Intervention: Tablet-based intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Tabletop intervention
Number of subjects: 22
Study: 27190329

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevelamer (SEV)
Number of subjects: 100
Study: 25553511

Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray during luteal phase
Number of subjects: 140
Study: 23514626

Group type: EXPERIMENTAL
Intervention: HMB (calcium salt, 1.5 g twice daily, total 3 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (inactive placebo powder)
Number of subjects: 24

Group type: COMPARATOR
Intervention: HMB vs Control
Number of subjects: 24

Group type: COMPARATOR
Intervention: HMB vs Control (female subjects)
Number of subjects: 24
Study: 21544683

Group type: EXPERIMENTAL
Intervention: Remote intermittent ischemia (RI) - three 5‐min cycles of left upper limb ischemia by cuff inflation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (Plac) - without cuff inflation
Number of subjects: 54
Study: 19523738

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide whitening strips (Crest Whitestrips)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo strips without peroxide
Number of subjects: 40
Study: 17530471

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg daily titrated every 3 months for 18 months)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (without lovastatin)
Number of subjects: 55
Study: 15476153

Group type: EXPERIMENTAL
Intervention: Renzapride 4 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Renzapride (1, 2, or 4 mg)
Number of subjects: 48
Study: 11404610

Group type: EXPERIMENTAL
Intervention: Hyperthermic, supersaturated humidification through a nasal cannula (Vapotherm Inc.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard bedside humidifier
Number of subjects: 0
Study: 8816337

Group type: COMPARATOR
Intervention: Stage II impingement syndrome (group 2)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Rotator cuff tears or stage III impingement (group 3)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal shoulders (group 1)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Stage II impingement syndrome (group 2) and Rotator cuff tears (group 3)
Number of subjects: 47
Study: 1428303

Group type: EXPERIMENTAL
Intervention: Acetyl-carnitine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 6145832

Group type: EXPERIMENTAL
Intervention: Combination of hormone therapies using tamoxifen, aminoglutethimide with hydrocortisone, and danazol (TAD)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 222

Group type: COMPARATOR
Intervention: Tamoxifen and/or subsequent endocrine therapy
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: TAD
Number of subjects: 222

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: TAD and Tamoxifen
Number of subjects: 222
Study: 31211607

Group type: EXPERIMENTAL
Intervention: Hypnotherapy (weekly session for 1 month, total of four sessions)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupressure (initial session guided by acupuncturist, 2 month take home supply of acupressure patches, reviewed fortnightly)
Number of subjects: 40
Study: 28969439

Group type: EXPERIMENTAL
Intervention: CCBT (computer-assisted cognitive-behavioral therapy) using the 'Good Days Ahead' program
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard CBT (cognitive-behavioral therapy)
Number of subjects: 154
Study: 26481083

Group type: COMPARATOR
Intervention: rosuvastatin 10 mg/d
Number of subjects: 12705

Group type: COMPARATOR
Intervention: candesartan/hydrochlorothiazide 16/12.5 mg/d
Number of subjects: 12705

Group type: COMPARATOR
Intervention: Combination of rosuvastatin and candesartan/hydrochlorothiazide
Number of subjects: 12705

Group type: COMPARATOR
Intervention: Placebo for rosuvastatin
Number of subjects: 12705

Group type: COMPARATOR
Intervention: Placebo for candesartan/hydrochlorothiazide
Number of subjects: 12705
Study: 24586490

Group type: EXPERIMENTAL
Intervention: Darapladib 40 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Darapladib 80 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 22257580

Group type: EXPERIMENTAL
Intervention: glimepiride/SR metformin 2 mg/500 mg
Number of subjects: 12
Study: 20961974

Group type: EXPERIMENTAL
Intervention: Attentional training intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 64
Study: 17586384

Group type: EXPERIMENTAL
Intervention: Square-edged PMMA IOL
Number of subjects: 118

Group type: COMPARATOR
Intervention: Round-edged PMMA IOL
Number of subjects: 118
Study: 16457090

Group type: EXPERIMENTAL
Intervention: Swedish version of the Fatigue Impact Scale (FIS)
Number of subjects: 355
Study: 12400767

Group type: EXPERIMENTAL
Intervention: PEEP of 10 cm H2O
Number of subjects: 84

Group type: COMPARATOR
Intervention: PEEP of 5 cm H2O
Number of subjects: 84
Study: 9972769

Group type: EXPERIMENTAL
Intervention: Rocuronium infusion to achieve a steady-state 50% block at the hand (n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rocuronium infusion to achieve a steady-state 75% block at the hand (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of cuff pressure measurement and video imaging (VI)
Number of subjects: 20
Study: 7587258

Group type: EXPERIMENTAL
Intervention: 40% potassium hydroxide preparations of tracheo-bronchial aspirates
Number of subjects: 22

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 22
Study: 1683332

Group type: EXPERIMENTAL
Intervention: Zotepine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 40
Study: 7041523

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 42

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 42
Study: 31937586

Group type: EXPERIMENTAL
Intervention: Rovatirelin 1.6 mg
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Rovatirelin 2.4 mg
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Rovatirelin 2.4 mg (pooled analysis)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 652
Study: 30893638

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) 600 mg/kg diet/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) 1200 mg/kg diet/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Guanidinoacetic acid (GAA) 1800 mg/kg diet/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Guanidinoacetic acid (GAA) 0 mg/kg diet/day (Control)
Number of subjects: 16
Study: 29169546

Group type: EXPERIMENTAL
Intervention: Telehealth electronic monitoring after arterial revascularization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard postdischarge care (implied control)
Number of subjects: 0
Study: 27797985

Group type: EXPERIMENTAL
Intervention: Optometrist-led follow-up monitoring reviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ophthalmologist-led follow-up monitoring reviews
Number of subjects: 0
Study: 24293455

Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg daily
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Fingolimod 5 mg daily
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 22914079

Group type: EXPERIMENTAL
Intervention: Enoxaparin 30 mg bid from 24 to 96 hours after injury
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 18608540

Group type: EXPERIMENTAL
Intervention: Potassium chloride-fortified bread (22 mmol/day potassium chloride)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Breads with 30% sodium replaced by potassium salts
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Breads with 10% wheat flour replaced with soy flour
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard bread
Number of subjects: 6
Study: 17464718

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg day(-1)) for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study: 15163892

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cessation of both therapies
Number of subjects: 0
Study: 11683695

Group type: EXPERIMENTAL
Intervention: 30 mg simplified lansoprazole suspension (nasogastrically)
Number of subjects: 36

Group type: COMPARATOR
Intervention: 40 mg intravenous pantoprazole
Number of subjects: 36
Study: 9712471

Group type: EXPERIMENTAL
Intervention: Nutritional supplements containing Ephedra sinica (ma huang)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 25‐mg ephedrine capsule
Number of subjects: 10
Study: 8308569

Group type: EXPERIMENTAL
Intervention: Rooming-in-hospital where formula supplementation was not allowed
Number of subjects: 165

Group type: COMPARATOR
Intervention: Nursery
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 165
Study: 3167527

Group type: EXPERIMENTAL
Intervention: Oral neomycin and erythromycin base (Group A)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Systemic metronidazole and gentamicin (Group B)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both oral and systemic antibiotics (Group C)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Oral antibiotics alone (Group A)
Number of subjects: 194
Study: 31788791

Group type: COMPARATOR
Intervention: Fast propofol infusion
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Slow propofol infusion
Number of subjects: 16
Study: 30266593

Group type: EXPERIMENTAL
Intervention: Legume-based TLC diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Legume-free TLC diet
Number of subjects: 31
Study: 28318353

Group type: EXPERIMENTAL
Intervention: Men with symptomatic heart failure
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Women with symptomatic heart failure
Number of subjects: 314

Group type: COMPARATOR
Intervention: Comparison of men to women
Number of subjects: 314
Study: 26124035

Group type: EXPERIMENTAL
Intervention: Angle Class II Division 2 malocclusion group
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (270 orthodontic patients: 168 female, 102 male)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (270 orthodontic patients)
Number of subjects: 76
Study: 22480831

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 211

Group type: COMPARATOR
Intervention: Emergency portacaval shunt
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Child-Turcotte score
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: MELD
Number of subjects: 211
Study: 20043136

Group type: EXPERIMENTAL
Intervention: DBDS-MPH (40 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: OROS-MPH (36 mg)
Number of subjects: 21
Study: 17652642

Group type: EXPERIMENTAL
Intervention: Selegiline 3 mg/24 hours
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Selegiline 6 mg/24 hours
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 16254085

Group type: EXPERIMENTAL
Intervention: Physical attractiveness of female faces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical attractiveness of male faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attractive female faces
Number of subjects: 0
Study: 12152371

Group type: EXPERIMENTAL
Intervention: Zirconia femoral head and alumina acetabular liner
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alumina femoral head and alumina acetabular liner
Number of subjects: 10
Study: 10201665

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 18
Study: 8529142

Group type: EXPERIMENTAL
Intervention: Computer Managed Instruction (CMI) and keypad questions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Classroom Lecture (TCL)
Number of subjects: 0
Study: 2141512

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (vincristine during irradiation and maintenance CCNU and vincristine, given in 6-weekly cycles for 1 year)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (craniospinal irradiation only)
Number of subjects: 286
Study: 41151

Group type: EXPERIMENTAL
Intervention: Nuclear Magnetic Resonance (NMR) imaging
Number of subjects: 47
Study: 30847706

Group type: EXPERIMENTAL
Intervention: Cooling brace
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 28340011

Group type: EXPERIMENTAL
Intervention: Upper limb exercises (group 1)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Lower limb exercises (group 2)
Number of subjects: 198

Group type: COMPARATOR
Intervention: No intervention (group 0)
Number of subjects: 198
Study: 27681888

Group type: EXPERIMENTAL
Intervention: DAA-I 0.08 mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: DAA-I 0.70 mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: DAA-I 1.50 mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 25090173

Group type: EXPERIMENTAL
Intervention: Linkage group (buprenorphine induction, intrahospital dose stabilization, and postdischarge transition to maintenance buprenorphine OAT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Detoxification group (five-day buprenorphine detoxification protocol)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Linkage group
Number of subjects: 145

Group type: COMPARATOR
Intervention: Detoxification group
Number of subjects: 145
Study: 22997755

Group type: EXPERIMENTAL
Intervention: Citoflavin included in the complex program of intensive therapy
Number of subjects: 48
Study: 20980215

Group type: EXPERIMENTAL
Intervention: Carvedilol controlled-release (CR)/lisinopril
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Atenolol/lisinopril
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 287

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 287
Study: 18982716

Group type: EXPERIMENTAL
Intervention: General anesthesia based on propofol with fentanyl combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various schemes of general anesthesia
Number of subjects: 0
Study: 16097225

Group type: EXPERIMENTAL
Intervention: Chin cup therapy with 600 g of force applied in 13 patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no orthodontic treatment)
Number of subjects: 20
Study: 11841593

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg p.o.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 10445787

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 500 mg + Metronidazole (MET) 3 x 250 mg/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 500 mg + Metronidazole (MET) 3 x 125 mg/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 250 mg + Metronidazole (MET) 3 x 125 mg/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Increase of MET dose from 375 mg (in groups B and C) to 750 mg/day (in group A)
Number of subjects: 131
Study: 7588498

Group type: EXPERIMENTAL
Intervention: Acetate (12 mmol/h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propionate (4 mmol/h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetate + Propionate (12 mmol/h + 4 mmol/h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Isotonic sodium salt solution (saline)
Number of subjects: 6
Study: 2179113

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg orally twice daily for seven days
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo capsule twice daily for seven days
Number of subjects: 216
Study: 6986970

Group type: EXPERIMENTAL
Intervention: Vincristine, Adriamycin and cyclophosphamide alternating with 5‐FU and methotrexate plus BCG or MER‐BCG immunotherapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: FAC‐BCG (historical control group)
Number of subjects: 156
Study: 31618992

Group type: EXPERIMENTAL
Intervention: HAMS (high amylose maize starch) 10 g/day for 2 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HAMSA (acetylated high amylose maize starch) 10 g/day for 2 weeks
Number of subjects: 20
Study: 28387790

Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel
Number of subjects: 3102

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 3102

Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel (subgroup of 188 subjects)
Number of subjects: 3102

Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel (after matching)
Number of subjects: 3102

Group type: COMPARATOR
Intervention: Aspirin alone (after matching)
Number of subjects: 3102
Study: 25470746

Group type: EXPERIMENTAL
Intervention: Doravirine (6-1,200 mg)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Doravirine (30-750 mg) once daily for 10 days
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Doravirine (50 mg) with a high-fat meal
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Doravirine (120 mg) coadministered with midazolam
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Doravirine (up to 1,200 mg single doses and up to 750 mg multiple doses)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 23402712

Group type: EXPERIMENTAL
Intervention: Healthy descriptive norm
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Healthy injunctive norm
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Unhealthy descriptive norm
Number of subjects: 687

Group type: COMPARATOR
Intervention: No-message control condition
Number of subjects: 687
Study: 21558406

Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 176

Group type: COMPARATOR
Intervention: control
Number of subjects: 176
Study: 19532104

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18727929

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) for 12 months with metronidazole for 3 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo for 12 months with metronidazole for 3 months
Number of subjects: 81
Study: 15909262

Group type: EXPERIMENTAL
Intervention: Azithromycin at 60 mg/kg per course
Number of subjects: 4626

Group type: EXPERIMENTAL
Intervention: Azithromycin at 30 mg/kg per course
Number of subjects: 4626

Group type: EXPERIMENTAL
Intervention: Three-day regimens of azithromycin (500 mg/day) in adults
Number of subjects: 4626

Group type: EXPERIMENTAL
Intervention: Five-day regimens of azithromycin in adults
Number of subjects: 4626

Group type: EXPERIMENTAL
Intervention: Three-day regimens vs. five-day regimens
Number of subjects: 4626

Group type: EXPERIMENTAL
Intervention: Clinical cure rates for different azithromycin regimens
Number of subjects: 4626

Group type: COMPARATOR
Intervention: 10-day comparator antibiotics
Number of subjects: 4626
Study: 11888128

Group type: EXPERIMENTAL
Intervention: Mechanical compression devices
Number of subjects: 12

Group type: COMPARATOR
Intervention: Various methods of compression
Number of subjects: 12
Study: 10534208

Group type: EXPERIMENTAL
Intervention: Trovafloxacin 200 mg once daily for 5 days
Number of subjects: 970

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 970
Study: 7872211

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (Ex)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) diet
Number of subjects: 23
Study: 2676266

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment with chlorthalidone and atenolol (or reserpine)
Number of subjects: 4736

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study: 282689

Group type: EXPERIMENTAL
Intervention: Pack modified by Behlke
Number of subjects: 27

Group type: COMPARATOR
Intervention: Zinc oxide-eugenol pack
Number of subjects: 27
Study: 31185327

Group type: EXPERIMENTAL
Intervention: Post-mastectomy intensity modulated proton therapy (IMPT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Hypofractionation (median 40.5 Gy/15 fractions)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Older patient age
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-irradiated contralateral breasts
Number of subjects: 51
Study: 28492874

Group type: EXPERIMENTAL
Intervention: Acetazolamide + weight management
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo + weight management
Number of subjects: 70

Group type: COMPARATOR
Intervention: Weight management alone
Number of subjects: 70
Study: 25964586

Group type: EXPERIMENTAL
Intervention: RapidArc® (RA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tomotherapy (TT)
Number of subjects: 16